Substantive final action
HB870
Senate Vote on HB 870 FINAL PASSAGE (#1021)
Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
Passed Senate May 19, 2026⭐ Substantive final action
Yea (33)
Absent (6)
Republicans (28)
100% yea among members casting a yea or nay vote (25–0).
Democrats (11)
100% yea among members casting a yea or nay vote (8–0).